SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $43,294 | -43.8% | 48,865 | -0.1% | 0.00% | – |
| Q3 2022 | $77,000 | -22.2% | 48,928 | -0.3% | 0.00% | -100.0% |
| Q2 2022 | $99,000 | -16.1% | 49,082 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $118,000 | -50.0% | 50,574 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $236,000 | -26.5% | 50,724 | +20.6% | 0.00% | -50.0% |
| Q3 2021 | $321,000 | -21.3% | 42,068 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $408,000 | +19.6% | 42,068 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $341,000 | +71.4% | 41,251 | +41.7% | 0.00% | +100.0% |
| Q4 2020 | $199,000 | +0.5% | 29,113 | +63.6% | 0.00% | 0.0% |
| Q3 2020 | $198,000 | +76.8% | 17,800 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $112,000 | +489.5% | 17,800 | +98.5% | 0.00% | – |
| Q3 2019 | $19,000 | -20.8% | 8,966 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -4.0% | 8,966 | +71.3% | 0.00% | – |
| Q1 2019 | $25,000 | +92.3% | 5,235 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | – | 5,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |